Key facts
- This page summarizes Michael Holder's Form 4 filing for AVITA Medical, Inc. (RCEL).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 06 Jul 2022, 18:57.
Michael Holder - 01 Jul 2022 Form 4 Insider Report for AVITA Medical, Inc. (RCEL)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- RCEL
- Reported as of
- 01 Jul 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 06 Jul 2022, 18:57:16 UTC
- Prior SEC filing
- 07 Sep 2021
- Next SEC filing
- 07 Jun 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Donna Shiroma, by power of attorney
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Michael Holder filed Form 4 for AVITA Medical, Inc. (RCEL) on 06 Jul 2022.
Change
- Previous filing in this sequence was filed on 07 Sep 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
RCEL
transaction
Common Stock
Award
- Transaction value
- Shares
- +35,950
- Change %
- +342%
- Price
- Shares after
- 46,450
- Date
- 01 Jul 2022
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
RCEL
transaction
Derivative
Stock Options (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +20,650
- Change %
- Price
- $0.000000
- Shares after
- 20,650
- Date
- 01 Jul 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 20,650
- Exercise price
- $4.97
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Reflects Restricted Stock Units, each representing a contingent right to be issued one share of Common Stock. These Restricted Stock Units vest in four equal annual installments beginning on August 20, 2023.
Footnote F2
Includes unvested Restricted Stock Units.
Footnote F3
These Stock Options vest in four equal annual installments beginning on August 20, 2023.